Pathological attachment of the placenta: diagnosis, management and delivery

Authors

DOI:

https://doi.org/10.15574/PP.2022.92.42

Keywords:

placenta previa, placenta accreta, placenta increta, women, pregnancy

Abstract

The incidence of placenta previa is 0.2-0.9% but continues to be one of the most serious factors in the development of obstetric’s bleeding and perinatal losses. The situation is aggravated by the fact that placenta previa is combined with various variations of abnormal (deep) attachment of the placenta to the uterus (placenta adhaerens, accreta, increta, percreta). Placenta previa, placenta accreta, and vasa previa cause significant maternal and perinatal morbidity and mortality. With the increasing incidence of both cesarean delivery and pregnancies using assisted reproductive technology, these 3 conditions are becoming more common. Placental accretion remains the main cause of maternal hemorrhage and obstetric hysterectomy, resulting in significantly high maternal morbidity and mortality. Risk factors for placenta previa include prior cesarean delivery, pregnancy termination, intrauterine surgery, smoking, multifetal gestation, increasing parity, and maternal age. Advances in ultrasound have facilitated prenatal diagnosis of abnormal placentation allowing the development of multidisciplinary management plans to achieve the best outcomes for mother and baby.

Purpose - to review the literature on abnormal placentation, including an evidence-based approach to diagnosis, management and treatment; to follow the evolution of this obstetric pathology in recent years and the complications that may arise. Identification of risk factors, correct antenatal and preoperative diagnosis, multidisciplinary treatment and counseling will help in the overall management of women with placenta accreta and reduce maternal morbidity.

According to the literature, it can be concluded that true placenta previa or placenta percreta, as well as suspected placenta previa (for example, in cases with a history of caesarean section in anamnesis), should be managed and delivered by caesarean section in a tertiary health facility. In no case should the placenta be separated if edematous blood vessels with visible placental blood flow after laparotomy are found in the area of attachment of the placenta to the anterior wall of the uterus, as well as when the diagnosis is placenta percreta or placenta increta. As a tactic, not only primary hysterectomy should be considered, but also conservative therapy or delayed hysterectomy (two-stage hysterectomy). In a situation where placenta accreta or partial placenta accreta cannot be accurately diagnosed, a good understanding of hemostasis with balloon catheter occlusion, various methods of suture hemostasis, and total hysterectomy procedures should be considered.

No conflict of interests was declared by the author.

References

Baldwin HJ, Patterson JA, Nippita TA, Torvaldsen S, Ibiebele I, Simpson JM, Ford JB. (2018, Feb). Antecedents of Abnormally Invasive Placenta in Primiparous Women: Risk Associated with Gynecologic Procedures. Obstet Gynecol. 131 (2): 227-233. https://doi.org/10.1097/AOG.0000000000002434; PMid:29324602

Becker RH, Vonk R, Mende BC, Ragosch V, Entezami M. (2001). The relevance of placental location at 20-23 gestational weeks for prediction of placenta previa at delivery: evaluation of 8650 cases. Ultrasound Obstet Gynecol. 7 (6): 496-501. https://doi.org/10.1046/j.1469-0705.2001.00423.x; PMid:11422970

Cheung CS, Chan BC. (2012). The sonographic appearance and obstetric management of placenta accreta. Int J Womens Health. 4: 587-594. https://doi.org/10.2147/IJWH.S28853; PMid:23239929 PMCid:PMC3516467

Chou MM, Tseng JJ, Ho ES, Hwang JI. (2001). Three-dimensional color power Doppler imaging in the assessment of uteroplacental neovascularization in placenta previa increta / percreta. Am J Obstet Gynecol. 185 (5): 1257-1260. https://doi.org/10.1067/mob.2001.115282; PMid:11717667

Committee on Obstetric Practice. (2002, Jan). ACOG committee opinion: placenta accrete. Number 266, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 77 (1): 77-78. https://doi.org/10.1016/S0020-7292(02)80003-0; PMid:12053897

Dashe JS, McIntire DD, Ramus RM, Santos-Ramos R, Twickler DM. (2002). Persistence of placenta previa according to gestational age at ultrasound detection. Obstet Gynecol. 99 (5 Pt 1): 692-697. https://doi.org/10.1097/00006250-200205000-00005; PMid:11978274

Esh-Broder E, Ariel I, Abas-Bashir N, Bdolah Y, Celnikier DH. (2011, Aug). Placenta accreta is associated with IVF pregnancies: a retrospective chart review. BJOG. 118 (9): 1084-1089. https://doi.org/10.1111/j.1471-0528.2011.02976.x; PMid:21585640

Finberg HJ, Williams JW. (1992). Placenta accreta: Prospective diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med. 11: 333-343. https://doi.org/10.7863/jum.1992.11.7.333; PMid:1522623

Hiramatsu Y, Konishi I, Sakuragi N, Takeda S, eds. (2010). Mastering the Essential Surgical Procedures OGS NOW, No.3. Cesarean section. (Japanese). Tokyo: Medical View: 102-115.

Jauniaux E RM, Alfirevic Z, Bhide A Get al. (2018). Placenta Praevia and Placenta Accreta: Diagnosis and Management (Green-top Guideline No. 27a). BJOG. 126: e1-e48. URL: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg27a. https://doi.org/10.1111/1471-0528.15306; PMid:30260097

Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S. (2018). FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet. 140 (3): 281-290. https://doi.org/10.1002/ijgo.12409; PMid:29405317

Love CD, Fernando KJ, Sargent L, Hughes RG. (2004). Major placenta praevia should not preclude out-patient management. Eur J Obstet Gynaecol Repr Biol. 117: 24-29. https://doi.org/10.1016/j.ejogrb.2003.10.039; PMid:15474239

Makino S, Tanaka T, Yorifuji T, Koshiishi T, Sugimura M, Takeda S. (2012). Double vertical compression sutures: a novel conservative approach to managing post-partum haemorrhage due to placenta praevia and atonic bleeding. Aust N Z J Obstet Gynaecol. 52 (3): 290-292. https://doi.org/10.1111/j.1479-828X.2012.01422.x; PMid:22413844

Mustafá SA, Brizot ML, Carvalho MH, Watanabe L, Kahhale S, Zugaib M. (2002). Transvaginal ultrasonography in predicting placenta previa at delivery: a longitudinal study. Ultrasound Obstet Gynecol. 20: 356-359. https://doi.org/10.1046/j.1469-0705.2002.00814.x; PMid:12383317

Neilson JP. (2003). Interventions for suspected placenta praevia. Cochrane Database Syst Rev: 2. https://doi.org/10.1002/14651858.CD001998; PMCid:PMC8411396

Ono Y, Murayama Y, Era S et al. (2018). Study of the utility and problems of common iliac artery balloon occlusion for placenta previa with accreta. J Obstet Gynaecol Res. 44 (3): 456-462. https://doi.org/10.1111/jog.13550; PMid:29297951 PMCid:PMC5873444

Oppenheimer L et al. (2007). Diagnosis and management of placenta previa. J Obstet Gynaecol Can. 29 (3): 261-266. https://doi.org/10.1016/S1701-2163(16)32401-X; PMid:17346497

Oyelese Y, Smulian JC. (2006, Apr). Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 107 (4): 927-941. https://doi.org/10.1097/01.AOG.0000207559.15715.98; PMid:16582134

Pelosi MA 3rd, Pelosi MA. (1999, May). Modified cesarean hysterectomy for placenta previa percreta with bladder invasion: retrovesical lower uterine segment bypass. Obstet Gynecol. 93 (5 Pt 2): 830-833. https://doi.org/10.1016/S0029-7844(98)00426-8; PMid:10912411

RCOG. (2011). Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management. London: Royal College of Obstetricians and Gynaecologists. Green-top Guideline No 27.

Royal College of Obstetricians and Gynaecologists Royal College of Midwives National Patient Safety Agency. Safer Practice in Intrapartum Care Project Care Bundles. (2010). Placenta praevia after previous lower-section caesarean segment care bundle. London: 23-31.

Sentilhes L, Kayem G, Silver RM. (2018). Conservative management of placenta accreta spectrum. Clin Obstet Gynecol. 61 (4): 783-794. https://doi.org/10.1097/GRF.0000000000000395; PMid:30222610

Shih JC, Palacios JM, Su YN, Shyu MK, Lin CH, Lin SY. (2009). Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol. 33: 193-203. https://doi.org/10.1002/uog.6284; PMid:19173239

Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY et al. (2006, Jun). Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 107 (6): 1226-1232. https://doi.org/10.1097/01.AOG.0000219750.79480.84; PMid:16738145

Sone M, Nakajima Y, Woodhams R et al. (2015). Interventional radiology for critical hemorrhage in obstetrics: Japanese Society of Interventional Radiology (JSIR) procedural guidelines. Jpn J Radiol. 33 (4): 233-240. https://doi.org/10.1007/s11604-015-0399-0; PMid:25694338

Sumigama S, Itakura A, Ota T et al. (2007). Placenta previa increta / percreta in Japan: a retrospective study of ultrasound findings, management and clinical course. J Obstet Gynaecol Res. 33 (5): 606-611. https://doi.org/10.1111/j.1447-0756.2007.00619.x; PMid:17845316

Takeda J, Makino S, Takeda S. (2019). Hemostasis for massive hemorrhage during cesarean section. Intech Open. In press. https://doi.org/10.5772/intechopen.86394

Takeda J, Makino S. (2018). Temporary arterial balloon occlusion for obstetrical field. Singapore: Springer: 33-39. https://doi.org/10.1007/978-981-10-8833-9_5; PMCid:PMC6364622

Takeda J, Takeda S. (2019). Management of disseminated intravascular coagulation associated with placental abruption and measures to improve outcomes. Obstet Gynecol Sci. 62 (5): 299-306. https://doi.org/10.5468/ogs.2019.62.5.299; PMid:31538072 PMCid:PMC6737058

Takeda S, Makino S, Takeda J et al. (2017). Japanese clinical practice guide for critical obstetrical hemorrhage (2017 revision). J Obstet Gynaecol Res. 43 (10): 1517-1521. https://doi.org/10.1111/jog.13417; PMid:28737252

Takeda S, Murayama Y. (2012). Cesarean hysterectomy for placenta previa accrete spectrum. Tokyo: Medical View: 122-133.

Takeda S, Takeda J, Makino S. (2019). A minimally invasive hemostatic strategy in obstetrics aiming to preserve uterine function and enhance the safety of subsequent pregnancies. Hypertens Res Pregnancy. 7 (1): 9-15. https://doi.org/10.14390/jsshp.HRP2018-013

Takeda S. (2010). Cesarean section for placenta previa and placenta previa accrete spectrum. Tokyo: Medical View: 102-115.

Ueda Y, Kondoh E, Kakui K et al. (2013). Serial magnetic resonance imaging of placenta percreta with bladder involvement during pregnancy and postpartum: a case report. J Obstet Gynaecol Res. 39 (1): 359-363. https://doi.org/10.1111/j.1447-0756.2012.01899.x; PMid:22672446

Wing DA, Paul RH, Millar LK. (1996, Oct). Management of the symptomatic placenta previa: a randomized, controlled trial of inpatient versus outpatient expectant management. Am J Obstet Gynecol. 175 (4 Pt 1): 806-811. https://doi.org/10.1016/S0002-9378(96)80003-2; PMid:8885726

Published

2022-12-28